Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition).
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Yu, Sun Juxian, Cai Jianqiang, Chen Minshan, Dai Chaoliu, Wen Tianfu, Xia Jinglin, Ying Mingang, Zhang Zhiwei, Zhang Xuewen, Fang Chihua, Shen Feng, An Ping, Cai Qingxian, Cao Jingyu, Zeng Zhen, Chen Gang, Chen Juan, Chen Ping, Chen Yongshun, Shan Yunfeng, Dang Shuangsuo, Guo Wei-Xing, He Jiefeng, Hu Heping, Huang Bin, Jia Weidong, Jiang Kexiang, Jin Yan, Jin Yongdong, Jin Yun, Li Gong, Liang Yun, Liu Enyu, Liu Hao, Peng Wei, Peng Zhenwei, Peng Zhiyi, Qian Yeben, Ren Wanhua, Shi Jie, Song Yusheng, Tao Min, Tie Jun, Wan Xueying, Wang Bin, Wang Jin, Wang Kai, Wang Kang, Wang Xin, Wei Wenjing, Wu Fei-Xiang, Xiang Bangde, Xie Lin, Xu Jianming, Yan Mao-Lin, Ye Yufu, Yue Jinbo, Zhang Xiaoxun, Zhang Yu, Zhang Aibin, Zhao Haitao, Zhao Weifeng, Zheng Xin, Zhou Hongkun, Zhou Huabang, Zhou Jun, Zhou Xinmin, Cheng Shu-Qun, Li Qiu, Chinese Association of Liver Cancer and Chinese Medical Doctor Association
Аннотация
SUMMARY: To better guide the whole-course management of HCC patients, the Chinese Association of Liver Cancer and the Chinese Medical Doctor Association has gathered multidisciplinary experts and scholars in relevant fields to formulate the "Chinese Expert Consensus on The Whole-Course Management of Hepatocellular Carcinoma (2023)."
KEY MESSAGES: This expert consensus, based on the current clinical evidence and experience, proposes surgical and nonsurgical HCC management pathways and involves 18 recommendations, including perioperative treatment, systematic treatment combined with local treatment, conversion treatment, special population management, symptomatic support treatment, and follow-up management.